Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

WVE

Wave Life Sciences, Inc.

Pharmaceutical Preparations · SIC 2834CIK 1631574Held by 6 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$43.0M
Net Income FY2025
$(204.0M)
EPS (Basic, as reported)
$-1.21
Net Margin FY2025
-478.3%
ROE FY2025
-39.4%
Total Equity
$518.0M
Shares Out
197M
Business description

Wave Life Sciences, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2013–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 1 → 43 +51.9% CAGR
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021⚑FY2022FY2023FY2024FY2025
Revenue1414162041411310843
Research & development(41)(79)(134)(175)(131)(122)(116)(130)(160)(183)
General & administrative(16)(27)(40)(49)(43)(46)(51)(51)(59)(75)
Total operating expenses(57)(106)(174)(224)(173)(168)(166)(181)(219)(258)
Operating income(55)(103)(160)(208)(153)(127)(163)(68)(110)(215)
Interest & investment income————10281010
Other income (expense), net111315352101311
Pre-tax income(55)(101)(147)(194)(151)(122)(161)(58)(97)(204)
Income tax expense(1)(1)00(1)0(1)(1)00
Net income(55)(102)(147)(194)(150)(122)(162)(58)(97)(204)
EPS — basic—————($2.36)($2.05)($0.54)($0.70)($1.21)
EPS — diluted—————($2.36)($2.05)($0.54)($0.70)($1.21)
Shares outstanding — basic (M)—————5279106138169
Shares outstanding — diluted (M)—————5279106138169

Showing the latest 10 of 13 fiscal years.

  • ⚑ Weighted-average shares changed ×1.52 between FY2021 and FY2022 — likely a stock split. Per-share figures on either side are as reported and not adjusted.

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.